Revenue growth masks margin erosion; freight headwind persists

EBITDA flat YoY (₹188.9 vs ₹187.7 Cr), but margin collapsed from 13.8% to 11.7%

Revenue +19.2% YoY but -17.9% QoQ; sequential decline signals Q1 was weak

Confirmed in call; improvement real but still depressed vs historical ~$10/ton

Q1 was 2.34 MT (down 26% QoQ). Management now allows ±10% variance = 9-11 MT range. Implies miss risk.

Stated confidently but contingent on macro normalization and Guinea quota system implementation

10-12 MT restated with ±10% variance (9-11 MT range). Not a cut, but implicit acknowledgment of execution risk after Q1 sequential volume drop (-26% QoQ to 2.34 MT).

15 MT by FY28 'absolutely' confirmed; ~$1B bauxite revenue calculated by management at normalized EBITDA/ton.

Management now guided USD 5.5–6/ton near-term (Q2–Q3 estimate), down from USD 10 historical run-rate. Recovery timeline vague ('couple of quarters' to 'little more than that').

No margin improvement timeline for India business. Bleaching clay under pressure (acid cost); value-add capex outcomes deferred 'couple of financial years'.

Expected before year-end; realizations likely flat near-term, tailwind only after quota system in place. Freight remains overhang.

Yes, absolutely.

Nimba targeting 14 MT long-term; Guinea exports ~200 MT total, so not material disruption. Ashapura can also participate in tenders.

Exploring nearby countries but rare earth not in scope; no material announcement expected short-term.

EBITDA neutral; purpose is sustainability/quality, not margin expansion. Helps maintain EBITDA in depressed markets.

8 MT is reasonable for now; expansion to 10–12 MT as volumes ramp, no near-term timeline.

MOU only; still studying details and operationalization. Maybe update next year, currently in development phase.

Selected products in piloting to commercialization; medium-term vision is >50% EBITDA from value-add. 1M+ tons grinding capacity globally largest.

Q2 typically weak; growth in Q3–Q4. ±10% variance to target. Broadly on track for year.

Trial production stage, revenues fairly low. Won't disclose until long-term roadmap is built.

EBITDA will remain similar near-term until freight stabilizes. Quota system or geopolitical improvement needed for recovery.

Freight remains very elevated. Q2 typically weak; Q3–Q4 strongest. Washing plant can help premiumize in tough environments.

USD 15M equivalent; operate-and-transfer model so won't reflect on balance sheet. Sustainability tool, not EBITDA driver.

Near-term USD 5.5–6; expect longer-term closer to USD 10 but no timeline. Very volatile; take with pinch of salt.

15 MT target + ~$1B bauxite sales at normalized prices. Infrastructure/partnerships ready. Dependent on benign macro and quota system.

Value-add initiatives: cat litter, foundry, oil & gas, kaolin (paper, paint with titanium dioxide replacement), advanced ceramics. Multi-year play.

Oil & gas products (elevated prices, increased production focus); new steel industry materials (replacing intl vendors); debottlenecking added supply.

Prior $700M+ target; 10–12 MT at normalized $/ton should deliver. Current uncertainty on freight/quota timeline.

Equates to ~$1B bauxite revenue at normalized EBITDA. Infrastructure + customers ready; dependent on macro normalization.

Based on current freight/bauxite price environment. Management explicit but hedged with 'pinch of salt' on volatility.

Contingent on freight normalization + Guinea quota system. No quarter/year provided; aspirational.

Outcomes deferred 'couple of financial years'; bleaching clay near-term headwind unabated.

Distributed across bentonite, white minerals, ceramics R&D. Timeline multi-year; ROI metrics not disclosed.

Boffa done, GSM by Q4, washery live. USD 15M washery on operate-and-transfer model (off-balance-sheet).

Ocean freight 'abnormal' and 'highly volatile'; pushing landed costs up, compressing FOB realizations and EBITDA. No visibility on when relief comes; Q2–Q3 likely impacted.

Q1 volumes 2.34 MT down 26% QoQ; annual target 10–12 MT now includes ±10% variance (9–11 MT). Q2 expected weak; heavy reliance on Q3–Q4 to hit high-end.

PAT down 4.9% YoY despite 19.2% revenue growth; EBITDA margin fell 270 bps (11.7% vs 13.8%). India bleaching clay hit by 5x acid cost; no recovery timeline. Near-term EBITDA/ton constrained.

Quota system is key catalyst for margin recovery (price support, freight reduction). Expected before year-end but no firm date; delay would push recovery into FY28.

Iron ore still in trial-stage production; no revenue disclosed. Capex risk if commercialization doesn't materialize on plan. Management deferred long-term guidance to 'next year or so'.